−£116k
−143%vs Jun 2024Active10823844Private limited companyWolverhampton
DISULFICAN LIMITED
Significant control: University Of Wolverhampton (25–50%), Weiguang Wang (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Disulfican Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Disulfican Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DISULFICAN LIMITED is an active private limited company (company number 10823844) incorporated on 16 June 2017, registered in Wolverhampton. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of −£116k and cash of £22k, with 4 employees on average. Net assets fell 143% on the prior period (£269k).
Peer position · net assets
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Ownership and control
- University Of Wolverhampton
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Weiguang Wang
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Weiguang Wang
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 June 20179 yrs ago
- Next accounts due
- 30 March 2027in 154 days
- Confirmation statement due
- 30 June 2027in 246 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£22k
−73%vs Jun 2024Not reported
4
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£116k | £22k | £0 | — | — | — | 4 |
| 30 June 2024 | £269k | £84k | £4,915 | — | — | — | 4 |
Cash per employee£5,565Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-115,985 at 30 June 2025
- Net assets down 25% or more on the prior period-143.2% vs prior period
- Incorporated five or more years agoIncorporated 16 June 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 246 days
- Next accounts duein 154 days
- Accounts period endNet liabilities £116k · small accounts
- Accounts period endNet assets £269k · small accounts
- Incorporated
08
Similar companies in Birmingham
- RESURGO GENETICS LIMITEDBromsgrove · inc. May 2017
- ACCUNEA LTD.Kidderminster · inc. Mar 2017
- GIFFORD BIOSCIENCE LIMITEDSolihull · inc. Feb 2017
- MRM GORE GROUP LTDBrierley Hill · inc. Jan 2017
- APARON LTDTamworth · inc. Nov 2016
- ASK PHARMA DEVELOPMENT LIMITEDBirmingham · inc. Aug 2016
All companies incorporated on 16 June 2017 · in Jun 2017.
09
Reminders for DISULFICAN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.